Company / Cash per Share
Co-Diagnostics, Inc. Cash per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$10.79
FY2025
5-year range
$0.09 / $10.79
FY2021-FY2025
Trend
+11382.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share changed +11382% YoY in FY2025, a notable deviation from the 8-year average annual change of +1852%.
Based on SEC 10-K filings.
10.79 in FY2025 with a 5-year CAGR of +34.2%.
Improved from $0.48 to $10.79 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +151.3%
- 5-Year CAGR
- +34.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share increased 11382.5% year-over-year.
- Lowest cash per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.79 | +11382.5% |
| FY2024 | $0.09 | -80.6% |
| FY2023 | $0.48 | -28.9% |
| FY2022 | $0.68 | -78.1% |
| FY2021 | $3.10 | +25.2% |
| FY2020 | $2.48 | +3485.7% |
| FY2019 | $0.07 | -75.9% |
| FY2018 | $0.29 | +183.9% |
| FY2017 | $0.10 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026